Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth
Journal of Psychopharmacology, Volume 34, No. 3, Year 2020
Notification
URL copied to clipboard!
Description
Background: The drugs commonly used to treat bipolar disorder have limited efficacy and drug discovery is hampered by the paucity of knowledge of the pathophysiology of this disease. This study aims to explore the role of microRNAs in bipolar disorder and understand the molecular mechanisms of action of commonly used bipolar disorder drugs. Methods: The transcriptional effects of bipolar disorder drug combination (lithium, valproate, lamotrigine and quetiapine) in cultured human neuronal cells were studied using next generation sequencing. Differential expression of genes (n=20) and microRNAs (n=6) was assessed and the differentially expressed microRNAs were confirmed with TaqMan MicroRNA Assays. The expression of the differentially expressed microRNAs were inhibited to determine bipolar disorder drug effects on their target genes (n=8). Independent samples t-test was used for normally distributed data and Kruskal-Wallis/Mann-Whitney U test was used for data not distributed normally. Significance levels were set at p<0.05. Results: We found that bipolar disorder drugs tended to increase the expression of miR-128 and miR-378 (p<0.05). Putative target genes of these microRNAs targeted pathways including those identified as “neuron projection development” and “axonogenesis”. Many of the target genes are inhibitors of neurite outgrowth and neurogenesis and were downregulated following bipolar disorder drug combination treatment (all p<0.05). The bipolar disorder drug combination tended to decrease the expression of the target genes (NOVA1, GRIN3A, and VIM), however this effect could be reversed by the application of microRNA inhibitors. Conclusions: We conclude that at a transcriptional level, bipolar disorder drugs affect several genes in concert that would increase neurite outgrowth and neurogenesis and hence neural plasticity, and that this effect is mediated (at least in part) by modulation of the expression of these two key microRNAs. © The Author(s) 2020.
Authors & Co-Authors
Kidnapillai, Srisaiyini
Australia, Geelong
Deakin University
Bortolasci, Chiara Cristina
Australia, Geelong
Deakin University
Panizzutti, B.
Brazil, Porto Alegre
Universidade Federal do Rio Grande do Sul
Spolding, Briana
Australia, Geelong
Deakin University
Connor, Timothy
Australia, Geelong
Deakin University
Crowley, Tamsyn M.
Australia, Geelong
Deakin University
Jamain, Stéphane
France, Creteil
Institut Mondor de Recherche Biomédicale
Gray, Laura J.
Australia, Geelong
Deakin University
Australia, Melbourne
The Florey
Leboyer, Marion
France, Creteil
Institut Mondor de Recherche Biomédicale
Berk, Michael
Australia, Melbourne
The Florey
Australia, Melbourne
Orygen Youth Health
Walder, Ken R.
Australia, Geelong
Deakin University
Statistics
Citations: 10
Authors: 11
Affiliations: 5
Identifiers
Doi:
10.1177/0269881119895534
ISSN:
02698811
Research Areas
Mental Health